Home » Topics » Articles » Insight

Insight
RSS

Biotech - Big Pharma Collaborations: New Agreements July 26-Oct. 19, 2000#

Oct. 23, 2000

Temperature Of The Flu Drug Battle Continues Steady Rise

Oct. 23, 2000

Clinical Trial Update: September 2000

Oct. 16, 2000

Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: September 2000

Oct. 16, 2000

FDA Submissions, Approvals And Other Actions: September 2000

Oct. 16, 2000

Analyst: Genzyme, TKT Battle Will Clarify FDA's Orphan Rule

Oct. 16, 2000

New Affymetrix Firm Enters Crowded Database Field

Oct. 9, 2000

Public Financing of Biotechnology: September 2000

Oct. 9, 2000

Other Financings Of Public Biotechnology Companies: September 2000

Oct. 9, 2000

Venture Capital And Corporate Investments In Biotechnology Companies: September 2000

Oct. 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...